Page last updated: 2024-12-07

astilbin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Astilbin is a flavonoid found in various plants, particularly in the genus *Spiraea*. It is a glycoside of the flavonoid taxifolin, composed of a taxifolin molecule linked to a glucose molecule. Astilbin is known for its potential antioxidant, anti-inflammatory, and neuroprotective effects. Research suggests that it may protect against oxidative stress, reduce inflammation, and improve cognitive function. Astilbin is being studied for its potential therapeutic applications in conditions such as Alzheimer's disease, cardiovascular disease, and cancer. Its antioxidant and anti-inflammatory properties make it a promising candidate for preventing and treating these conditions.'

astilbin: dihydroflavonol from Kohki tea processed from Engelhardtia chrysolepis (huang-qui); astilbin is the (2R-trans)-isomer; neoisoastilbin is the (2S-cis)-isomer and is Sweetening Agents; isoastilbin is the (2R-cis)-isomer; structure in first source; [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

astilbin : A flavanone glycoside that is (+)-taxifolin substituted by a alpha-L-rhamnosyl moiety at position 3 via a glycosidic linkage. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
Chrysolepisgenus[no description available]FagaceaeA plant family of the order Fagales subclass Hamamelidae, class Magnoliopsida.[MeSH]

Cross-References

ID SourceID
PubMed CID119258
CHEMBL ID486017
CHEBI ID38200
MeSH IDM0260122

Synonyms (38)

Synonym
astilbin
CHEBI:38200 ,
dihydroquercetin-3-o-alpha-lrhap
29838-67-3
(2r,3r)-3-[(6-deoxy-alpha-l-mannopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-4h-1-benzopyran-4-one
(2r,3r)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-3,4-dihydro-2h-1-benzopyran-4-one
(2r,3r)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-3,4-dihydro-2h-chromen-3-yl 6-deoxy-alpha-l-mannopyranoside
MEGXP0_000363
ACON1_000616
NCGC00168909-01
C17449
CHEMBL486017
(2r,3r)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3-dihydrochromen-4-one
4h-1-benzopyran-4-one, 3-((6-deoxy-alpha-l-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-, (2r,3r)-
4h-1-benzopyran-4-one, 3-((6-deoxy-alpha-l-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-, (2r-trans)-
(2r-trans)-3-((6-deoxy-alpha-l-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-4h-1-benzopyran-4-one
S3932
taxifolin 3-rhamnoside
taxifolin 3-o-rhamnoside
Q-100379
4h-1-benzopyran-4-one, 3-[(6-deoxy-.alpha.-l-mannopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-, (2r,3r)-
dihydroquercitrin
dihydroquercetin 3-rhamnoside
ZROGCCBNZBKLEL-MPRHSVQHSA-N
dihydroquercetin 3-o-.alpha.-l-rhamnopyranoside
AKOS025402308
AC-8008
astilbin from engelhardtia roxburghiana, >=98%
CS-0009049
HY-N0509
Q4810880
(2r,3r)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)chroman-4-one
BS-16813
DTXSID501019948
AMY22307
4h-1-benzopyran-4-one,3-[(6-deoxy-a-l-mannopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-, (2r,3r)-
CCG-269236
(2r,3s)-3-[(6-deoxy--l-mannopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-4h-1-benzopyran-4-one; (2r,3s)-astilbin

Research Excerpts

Overview

Astilbin (ASB) is a dihydroflavonol, abundantly reported in multiple plants that has various pharmacological properties. Astilbin is a potential agent for autoimmune and inflammatory diseases and has a protective effect in mice with DSS-induced colitis.

ExcerptReferenceRelevance
"Astilbin is a dihydroflavanol found in many plants and processed foods. "( The natural source, physicochemical properties, biological activities and metabolism of astilbin.
Yang, D; Zhang, QF, 2023
)
2.58
"Astilbin is a promising candidate drug for psoriasis. "( Optimization of the Transdermal Delivery System in Astilbin Microemulsion with Improved Stability and Anti-psoriatic Activity.
Ding, Y; Liu, L; Wang, Y; Wu, Y; Zhao, R, 2023
)
2.6
"Astilbin is a dihydroflavonol glycoside identified in many natural plants and functional food with promising biological activities which is used as an antioxidant in the pharmaceutical and food fields. "( Molecular Insight into the Binding of Astilbin with Human Serum Albumin and Its Effect on Antioxidant Characteristics of Astilbin.
Gao, S; Han, X; Mao, B; Niu, T; Sun, J; Sun, L; Zhao, P, 2022
)
2.44
"Astilbin (ASB) is a dihydroflavonol, abundantly reported in multiple plants that has various pharmacological properties."( Attenuative effect of astilbin on polystyrene microplastics induced testicular damage: Biochemical, spermatological and histopathological-based evidences.
Anwar, H; Hamza, A; Ijaz, MU; Rizwan, A, 2023
)
1.95
"Astilbin is a type of flavonoid compound found in plants that plays a crucial role in providing powerful antioxidant and anti-inflammatory properties."( Astilbin targeted Sirt1 to inhibit acetylation of Nrf2 to alleviate grass carp hepatocyte apoptosis caused by PCB126-induced mitochondrial kinetic and metabolism dysfunctions.
Chen, S; Jiang, Q; Li, S; Wang, X; Xia, Y; Xu, S; Zhao, B, 2023
)
3.07
"Astilbin is a potential agent for autoimmune and inflammatory diseases and has a protective effect in mice with DSS-induced colitis. "( Astilbin promotes the induction of regulatory NK1.1
Deng, B; Ding, Y; Gong, W; Han, S; Jia, X; Lin, Z; Lu, G; Wen, J; Wu, K; Xiao, W; Xu, Y; Zhang, Y, 2020
)
3.44
"Astilbin is a natural flavonoid compound with various physiological activities."( Astilbin protects against cerebral ischaemia/reperfusion injury by inhibiting cellular apoptosis and ROS-NLRP3 inflammasome axis activation.
Li, Y; Wang, R; Xue, L; Yang, Y; Zhi, F, 2020
)
2.72
"Astilbin is a bioactive ingredient found in many medicinal and food plants, with antioxidative, anti-inflammatory, and antitumor properties."( Astilbin Protects Against Carbon Tetrachloride-Induced Liver Fibrosis in Rats.
Fan, XP; Sun, XH; Wang, ZH; Zhang, H, 2021
)
2.79
"Astilbin is an active flavonoid compound isolated from Rhizoma Smilacis Glabrae. "( Nonclinical safety of astilbin: A 4-week oral toxicity study in rats with genotoxicity, chromosomal aberration, and mammalian micronucleus tests.
Fan, X; Gao, Y; Lee, AW; Li, C; Li, G; Li, Y; Liu, Y; Tian, J; Wang, Y, 2017
)
2.21
"Astilbin is a dihydroflavonol derivative found in many medicinal and food plants with multiple pharmacological functions."( Astilbin alleviates sepsis-induced acute lung injury by inhibiting the expression of macrophage inhibitory factor in rats.
Li, W; Qi, ZW; Sun, LC; Wen, QK; Yan, ST; Zhang, GQ; Zhang, HB; Zhi, LD, 2017
)
2.62
"Astilbin is a flavonoid compound derived from the rhizome of Smilax china L. "( Astilbin improves potassium oxonate-induced hyperuricemia and kidney injury through regulating oxidative stress and inflammation response in mice.
Chen, J; Wang, M; Zhang, N; Zhao, J, 2016
)
3.32
"Astilbin is a flavonoid compound isolated from the rhizome of Smilax china L. "( Astilbin attenuates hyperuricemia and ameliorates nephropathy in fructose-induced hyperuricemic rats.
Chen, L; Lan, Z; Li, F; Li, P; Yang, Z; Zhang, C; Zhang, X; Zhou, Y, 2011
)
3.25
"Astilbin is considered to be a new and promising immunosuppressant for immune related diseases, but limited in clinical application due to its poor water solubility, difficult oral absorption and low bioavailability."( PVP and surfactant combined carrier as an effective absorption enhancer of poorly soluble astilbin in vitro and in vivo.
Du, Z; He, Y; Lai, X; Liao, Q; Liu, H; Xie, Z, 2014
)
2.07
"Astilbin is a flavonoid isolated from the rhizome of Smilax glabra. "( Identification of a new metabolite of astilbin, 3'-O-methylastilbin, and its immunosuppressive activity against contact dermatitis.
Chen, T; Guo, J; Li, J; Qian, F; Xu, Q, 2007
)
2.05

Effects

Astilbin has anti-inflammatory and immunoregulatory effects, and is frequently used in prescriptions treating psoriasis. Isoastilbin (IAB) has been shown to have antioxidative and anti-apoptotic functions.

ExcerptReferenceRelevance
"Astilbin has a therapeutic effect on RSA in rats by regulating the balance of Th1/Th2 in maternal circulation and likely in decidual tissue."( Astilbin improves pregnancy outcome in rats with recurrent spontaneous abortion by regulating Th1/Th2 balance.
Jiang, W; Pei, Y; Qian, Y; Zheng, C, 2022
)
3.61
"Isoastilbin (IAB) has been shown to have antioxidative and anti-apoptotic functions. "( Isoastilbin inhibits neuronal apoptosis and oxidative stress in a rat model of ischemia-reperfusion injury in the brain: Involvement of SIRT1/3/6.
An, L; Huang, J; Lu, G; Zhang, X; Zhu, D, 2022
)
1.96
"Astilbin has a therapeutic effect on RSA in rats by regulating the balance of Th1/Th2 in maternal circulation and likely in decidual tissue."( Astilbin improves pregnancy outcome in rats with recurrent spontaneous abortion by regulating Th1/Th2 balance.
Jiang, W; Pei, Y; Qian, Y; Zheng, C, 2022
)
3.61
"Astilbin (AS) has been confirmed to be an attractive candidate drug for psoriasis; however, the low oral absorption limits its further development and utilization. "( Citric Acid Enhances the Activities of Astilbin on Psoriasis via Down-Regulation of
Liu, L; Lu, C; Wu, Y; Zhao, R; Zhao, Y, 2023
)
2.62
"Astilbin has anti-inflammatory and immunoregulatory effects, and is frequently used in prescriptions treating psoriasis; however, the mechanism remains to be fully elucidated. "( Astilbin emulsion improves guinea pig lesions in a psoriasis-like model by suppressing IL-6 and IL-22 via p38 MAPK.
Lu, C; Xiao, Z; Yu, J; Zhang, Y; Zhao, R, 2018
)
3.37

Actions

Astilbin can inhibit maturation of mouse bone marrow-derived DCs with dose-dependent effect and exert negative effects on immunologic function of the DCs. Astilbin may enhance the vanadate-stimulated release of LPL activity.

ExcerptReferenceRelevance
"Astilbin can inhibit maturation of mouse bone marrow-derived DCs with dose-dependent effect and exert negative effects on immunologic function of the DCs."( [Effects of astilbin on maturation and immunologic function of mouse bone marrow-derived dendritic cells].
Ding, GS; Fu, ZR; Liu, F; Shen, XY; Song, SH; Wang, ZM, 2010
)
2.18
"Astilbin may enhance the vanadate-stimulated release of LPL activity through a synergistic effect on an increase in the cellular cAMP content produced by vanadate accompanied by more potent activation of PKA."( Enhancement of the vanadate-stimulated release of lipoprotein lipase activity by astilbin from the leaves of Engelhardtia chrysolepis.
Masuda, H; Miyake, M; Mizutani, K; Morita, T; Motoyashiki, T; Ueki, H, 1998
)
1.25

Treatment

Isoastilbin treatment attenuated MCAO/R-induced neuronal apoptosis. Treatment with astilbin decreases TNF alpha expression but induces IL-10 expression in liver during warm ischemia-reperfusion injury. Astilbin significantly decreased collagen production, inflammatory response, and oxidative stress in vivo.

ExcerptReferenceRelevance
"Isoastilbin treatment attenuated MCAO/R-induced neuronal apoptosis compared with the MCAO/R group, as indicated by the results of terminal deoxynucleotide transferase-mediated X-dUTP nick end (TUNEL) and western blot assays."( Isoastilbin inhibits neuronal apoptosis and oxidative stress in a rat model of ischemia-reperfusion injury in the brain: Involvement of SIRT1/3/6.
An, L; Huang, J; Lu, G; Zhang, X; Zhu, D, 2022
)
1.86
"Astilbin treatment significantly increased GATA-3 expression, while it significantly reduced T-bet expression and the T-bet/GATA-3 ratio."( Astilbin improves pregnancy outcome in rats with recurrent spontaneous abortion by regulating Th1/Th2 balance.
Jiang, W; Pei, Y; Qian, Y; Zheng, C, 2022
)
2.89
"Astilbin treatment significantly decreased collagen production, inflammatory response, and oxidative stress in vivo."( Astilbin Protects Against Carbon Tetrachloride-Induced Liver Fibrosis in Rats.
Fan, XP; Sun, XH; Wang, ZH; Zhang, H, 2021
)
2.79
"Astilbin treatment also dramatically decreased the production of inflammatory cytokines and chemokines in bronchoalveolar lavage fluid."( Astilbin alleviates sepsis-induced acute lung injury by inhibiting the expression of macrophage inhibitory factor in rats.
Li, W; Qi, ZW; Sun, LC; Wen, QK; Yan, ST; Zhang, GQ; Zhang, HB; Zhi, LD, 2017
)
2.62
"Treatment with astilbin decreases TNF alpha expression but induces IL-10 expression in liver during warm ischemia-reperfusion injury."( [Effects of astilbin on the expression of TNF alpha and IL-10 in liver warm ischemia-reperfusion injury].
Ai, QB; Dong, SL; Lin, RK; Mu, N; Wang, QX; Yao, QY; Zhang, CH, 2010
)
1.09

Toxicity

ExcerptReferenceRelevance
" Astilbin administration did not lead to death, body weight gain, food consumption, or adverse events."( Nonclinical safety of astilbin: A 4-week oral toxicity study in rats with genotoxicity, chromosomal aberration, and mammalian micronucleus tests.
Fan, X; Gao, Y; Lee, AW; Li, C; Li, G; Li, Y; Liu, Y; Tian, J; Wang, Y, 2017
)
1.68

Pharmacokinetics

The purpose of this study is to reveal the pharmacokinetic profiles of astilbin with various doses in rats. It also investigated the oral absolute bioavailability and tissue distribution of Astilbin after oral administration.

ExcerptReferenceRelevance
"To establish a SPE-HPLC method for analyzing astilbin in rats serum and explore the effects of Yinxieling (YXL) prescription and Smilacis Glabrae Rhizoma on the pharmacokinetic characteristics of effective components."( [Comparative pharmacokinetics study of astilbin after oral administration of Yinxieling prescription or Smilacis Glabrae Rhizoma to rats].
Lu, C; Wang, Y; Zhao, R, 2012
)
0.91
" Significant diffenerce in pharmacokinetic parameter of astilbin including t1/2, Cmax, AUC(0-t), AUC(0-infinity) and MRT were obtained through non-compartment model after oral administration of YXL prescription comparing with Smilacis Glabrae Rhizoma."( [Comparative pharmacokinetics study of astilbin after oral administration of Yinxieling prescription or Smilacis Glabrae Rhizoma to rats].
Lu, C; Wang, Y; Zhao, R, 2012
)
0.89
"The method was applied to a pharmacokinetic study of astilbin."( [Comparative pharmacokinetics study of astilbin after oral administration of Yinxieling prescription or Smilacis Glabrae Rhizoma to rats].
Lu, C; Wang, Y; Zhao, R, 2012
)
0.9
"The purpose of this study is to reveal the pharmacokinetic profiles of astilbin with various doses in rats and investigate the oral absolute bioavailability and tissue distribution of astilbin after oral administration."( Pharmacokinetic, bioavailability and tissue distribution study of astilbin in rats.
Shi, M; Xu, M; Yin, L, 2020
)
1.03

Compound-Compound Interactions

ExcerptReferenceRelevance
"This study illustrated the capacity of the sensitive UHPLC-Q-Exactive mass spectrometer analytical system combined with the data-mining methods to rapidly elucidate the unknown metabolism."( Comprehensive Identification of Astilbin Metabolites in Rats Based on Multiple Metabolite Templates Combined with UHPLC-Q-Exactive Mass Spectrometry.
Dai, L; Dong, F; Dong, P; Jiang, S; Li, H; Wang, S; Yang, A; Zhang, H; Zhang, J, 2021
)
0.9

Bioavailability

The oral absolute bioavailability of astilbin is poor because of the low permeability and solubility. The main purpose of this research work was to design an optimized self micro-emulsifying drug delivery system (SMEDDS)

ExcerptReferenceRelevance
" These results indicated that P-glycoprotein and Multidrug Resistance Protein 2 might play important roles in limiting the bioavailability of those compounds."( Permeation of astilbin and taxifolin in Caco-2 cell and their effects on the P-gp.
Gao, LB; Liu, T; Meng, MX; Wang, XD; Xu, Q; Zeng, S, 2009
)
0.71
" Co-effectors in the extract improve the bioavailability of active constituents such as hypericin (1) (pharmacokinetic synergy)."( Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).
Butterweck, V; Nahrstedt, A, 2010
)
0.36
"The main purpose of this research work was to design an optimized self micro-emulsifying drug delivery system (SMEDDS) to enhance the bioavailability of the poor water soluble drug, astilbin."( Optimized self-microemulsifying drug delivery systems (SMEDDS) for enhanced oral bioavailability of astilbin.
Bourkaib, N; Ke, X; Mezghrani, O; Xu, BH, 2011
)
0.78
" It indicated that the bioavailability of astilbin in YXL enhanced in rats and one of the reasons may be that components of prescription affect the pharmacokinetics of astilbin in vivo."( [Comparative pharmacokinetics study of astilbin after oral administration of Yinxieling prescription or Smilacis Glabrae Rhizoma to rats].
Lu, C; Wang, Y; Zhao, R, 2012
)
0.91
"The purpose of this study is to reveal the pharmacokinetic profiles of astilbin with various doses in rats and investigate the oral absolute bioavailability and tissue distribution of astilbin after oral administration."( Pharmacokinetic, bioavailability and tissue distribution study of astilbin in rats.
Shi, M; Xu, M; Yin, L, 2020
)
1.03
"The oral absolute bioavailability of astilbin is poor because of the low permeability and solubility."( Pharmacokinetic, bioavailability and tissue distribution study of astilbin in rats.
Shi, M; Xu, M; Yin, L, 2020
)
1.07
" In the present study, their solubility, stability, and bioavailability were compared in a rat."( A Comparison of Solubility, Stability, and Bioavailability between Astilbin and Neoastilbin Isolated from
Ruan, YT; Yin, ZP; Zhang, QF; Zheng, D, 2020
)
0.79

Dosage Studied

To establish a method for the determination of astilbin, peoniflorin, rasmarinci acid, isofraxidin and liquiritin contained in Shaolin Xiaoyin tablets.

ExcerptRelevanceReference
"C57BL/ 6 mice were randomly divided into 4 groups (n = 8): sham-operated group (Sham), model control group(I/R), low dosage of astilbin treatment group (10 mg/kg) and high dosage of astilbin (40 mg/kg) treatment group."( [Effects of astilbin on the expression of TNF alpha and IL-10 in liver warm ischemia-reperfusion injury].
Ai, QB; Dong, SL; Lin, RK; Mu, N; Wang, QX; Yao, QY; Zhang, CH, 2010
)
0.95
"To establish a method for the determination of astilbin, peoniflorin, rasmarinci acid, isofraxidin and liquiritin contained in Shaolin Xiaoyin tablets, in order to lay a foundation for designing late-stage dosage forms and clinical medication schemes."( [Pharmacokinetic study on peoniflorin, astilbin, rosmarinic acid, isofraxidin and liquiritin in rat blood after oral administration of shaolin xiaoyin tablets].
Feng, LM; Lu, CJ; Wang, YJ; Zhao, RZ, 2014
)
0.93
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
radical scavengerA role played by a substance that can react readily with, and thereby eliminate, radicals.
anti-inflammatory agentAny compound that has anti-inflammatory effects.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (6)

ClassDescription
alpha-L-rhamnoside
3'-hydroxyflavanonesAny hydroxyflavanone with a hydroxy substituent at position 3' of the phenyl ring.
tetrahydroxyflavanoneA hydroxyflavanone with atleast four hydroxy substituents.
flavanone glycosideA member of the class of flavanones having one or more glycosyl residues attached at unspecified positions.
monosaccharide derivativeA carbohydrate derivative that is formally obtained from a monosaccharide.
4'-hydroxyflavanonesAny hydroxyflavanone having a hydroxy substituent located at position 4'.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID478692Antidepressant activity in rat assessed as immobility time at 0.6 mg/kg, po by forced swimming test (Rvb = 150.3 +/- 11.1 sec)2010Journal of natural products, May-28, Volume: 73, Issue:5
Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).
AID338974Inhibition of cow milk xanthine oxidase at 50 ug/mL
AID402066Effect on lipolysis in cell-free system consisting sonicated lipid droplets assessed as free fatty acid release at 1000 ug in presence of hormone-sensitive lipase relative to untreated control1998Journal of natural products, Aug, Volume: 61, Issue:8
Norepinephrine-augmenting lipolytic effectors from Astilbe thunbergii rhizomes.
AID402069Stimulation of ACTH-induced lipolysis in Wistar rat fat cells assessed as free fatty acid release per mL of packed fat cells at 1000 ug after 1 hr relative to ACTH1998Journal of natural products, Aug, Volume: 61, Issue:8
Norepinephrine-augmenting lipolytic effectors from Astilbe thunbergii rhizomes.
AID402065Enhancement of norepinephrine-induced lipolysis in cell-free system consisting endogenous lipid droplets from Wistar rat fat cells assessed as free fatty acid release per mL of packed fat cells after 1 hr in presence of hormone-sensitive lipase1998Journal of natural products, Aug, Volume: 61, Issue:8
Norepinephrine-augmenting lipolytic effectors from Astilbe thunbergii rhizomes.
AID402070Inhibition of insulin-induced lipogenesis from [U-14C]glucose in Wistar rat fat cells after 1 hr by liquid scintillation counting1998Journal of natural products, Aug, Volume: 61, Issue:8
Norepinephrine-augmenting lipolytic effectors from Astilbe thunbergii rhizomes.
AID478693Antidepressant activity in rat assessed as immobility time at 1.3 mg/kg, po by forced swimming test (Rvb = 150.3 +/- 11.1 sec)2010Journal of natural products, May-28, Volume: 73, Issue:5
Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).
AID402067Enhancement of norepinephrine-induced lipolysis in cell-free system consisting sonicated lipid droplets assessed as free fatty acid release at 1000 ug in presence of hormone-sensitive lipase relative to untreated control1998Journal of natural products, Aug, Volume: 61, Issue:8
Norepinephrine-augmenting lipolytic effectors from Astilbe thunbergii rhizomes.
AID402063Enhancement of norepinephrine-induced lipolysis in Wistar rat fat cells assessed as free fatty acid release per mL of packed fat cells after 1 hr relative to norepinephrine1998Journal of natural products, Aug, Volume: 61, Issue:8
Norepinephrine-augmenting lipolytic effectors from Astilbe thunbergii rhizomes.
AID402064Induction of lipolysis in Wistar rat fat cells assessed as free fatty acid release per mL of packed fat cells after 1 hr relative to norepinephrine1998Journal of natural products, Aug, Volume: 61, Issue:8
Norepinephrine-augmenting lipolytic effectors from Astilbe thunbergii rhizomes.
AID402068Stimulation of ACTH-induced lipolysis in Wistar rat fat cells assessed as free fatty acid release per mL of packed fat cells at 100 ug after 1 hr relative to ACTH1998Journal of natural products, Aug, Volume: 61, Issue:8
Norepinephrine-augmenting lipolytic effectors from Astilbe thunbergii rhizomes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (141)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's12 (8.51)18.2507
2000's31 (21.99)29.6817
2010's67 (47.52)24.3611
2020's31 (21.99)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.08 (24.57)
Research Supply Index4.96 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index42.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (2.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other139 (97.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]